Qiagen N.V. (QGEN)
NYSE: QGEN · Real-Time Price · USD
39.85
+0.20 (0.50%)
At close: Mar 28, 2025, 4:00 PM
39.61
-0.25 (-0.61%)
After-hours: Mar 28, 2025, 4:59 PM EDT
Qiagen Revenue
In the year 2024, Qiagen had annual revenue of $1.98B with 0.66% growth. Qiagen had revenue of $521.20M in the quarter ending December 31, 2024, with 2.36% growth.
Revenue (ttm)
$1.98B
Revenue Growth
+0.66%
P/S Ratio
4.50
Revenue / Employee
$331,526
Employees
5,967
Market Cap
8.61B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.98B | 12.90M | 0.66% |
Dec 31, 2023 | 1.97B | -176.21M | -8.23% |
Dec 31, 2022 | 2.14B | -110.14M | -4.89% |
Dec 31, 2021 | 2.25B | 381.31M | 20.39% |
Dec 31, 2020 | 1.87B | 343.92M | 22.53% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionQGEN News
- 22 days ago - QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio - Business Wire
- 25 days ago - QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing - Business Wire
- 4 weeks ago - Qiagen N.V.: Some Clarity Needed Before Buying The Dip - Seeking Alpha
- 6 weeks ago - QIAGEN Strengthens Global Bioinformatics Leadership With New Data Center in Australia/Asia-Pacific Region - Business Wire
- 7 weeks ago - Qiagen N.V. (QGEN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - QIAGEN delivers solid Q4 2024 growth ahead of outlook - Business Wire
- 7 weeks ago - QIAGEN receives positive court decision reaffirming an important QuantiFERON-TB patent - Business Wire
- 2 months ago - QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $300 Million - Business Wire